T Scientific Co.,Ltd. (KOSDAQ:057680)
586.00
+9.00 (1.56%)
At close: Apr 8, 2026
T Scientific Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12,358 | 3,082 | 8,484 | 11,099 | 4,250 |
Short-Term Investments | 1,097 | 3,880 | 5,464 | 23,701 | 17,386 |
Cash & Short-Term Investments | 13,455 | 6,962 | 13,947 | 34,799 | 21,636 |
Cash Growth | 93.26% | -50.08% | -59.92% | 60.84% | 484.28% |
Accounts Receivable | 4,608 | 5,485 | 2,430 | 4,784 | 7,281 |
Other Receivables | 7,595 | 6,978 | 11,251 | 386.71 | 81.35 |
Receivables | 12,232 | 12,551 | 14,139 | 6,170 | 8,362 |
Inventory | 194.02 | 285.43 | 198.4 | 30.55 | - |
Prepaid Expenses | 97.04 | 130.28 | 101.25 | 28.24 | 27.41 |
Other Current Assets | 2,980 | 2,635 | 2,650 | 4,700 | 872.22 |
Total Current Assets | 28,958 | 22,563 | 31,037 | 45,728 | 30,898 |
Property, Plant & Equipment | 2,191 | 2,183 | 1,513 | 2,342 | 517.99 |
Long-Term Investments | 158,120 | 120,475 | 124,697 | 183,025 | 263,724 |
Goodwill | 2,295 | 3,552 | 1,354 | 26,822 | - |
Other Intangible Assets | 197.99 | 246.48 | 375.66 | 358.65 | 292.67 |
Long-Term Deferred Tax Assets | - | - | - | 2,991 | - |
Other Long-Term Assets | 9,499 | 13,649 | 14,995 | 1,272 | 852.59 |
Total Assets | 201,275 | 162,670 | 173,981 | 262,538 | 296,285 |
Accounts Payable | 2,864 | 3,234 | 4,437 | 5,251 | 7,200 |
Accrued Expenses | 419.3 | 419.15 | 335.39 | 197.22 | 48.58 |
Short-Term Debt | - | 4,185 | 11,697 | - | - |
Current Portion of Long-Term Debt | 270 | 1,300 | 1,000 | 26,574 | 16,747 |
Current Portion of Leases | 324.16 | 388.21 | 276 | 212.32 | 77.87 |
Current Income Taxes Payable | - | - | - | 3,980 | - |
Other Current Liabilities | 10,950 | 12,033 | 22,989 | 8,801 | 8,064 |
Total Current Liabilities | 14,827 | 21,559 | 40,735 | 45,017 | 32,136 |
Long-Term Debt | 5,061 | - | - | 10,496 | - |
Long-Term Leases | 956.6 | 861.29 | 112.3 | 977.91 | 18.57 |
Pension & Post-Retirement Benefits | 502.06 | 304.76 | 277.37 | 77.49 | 64.81 |
Long-Term Deferred Tax Liabilities | 6,534 | - | - | 17,799 | 42,173 |
Other Long-Term Liabilities | 3,187 | 144.04 | 2,305 | 7,555 | 0 |
Total Liabilities | 31,068 | 22,869 | 43,430 | 81,922 | 74,393 |
Common Stock | 35,717 | 35,717 | 34,347 | 27,724 | 23,759 |
Additional Paid-In Capital | 101,030 | 98,614 | 99,064 | 71,148 | 47,796 |
Retained Earnings | -73,708 | -72,548 | -73,459 | -27,871 | -16,692 |
Treasury Stock | - | - | -534.37 | -534.37 | -534.37 |
Comprehensive Income & Other | 107,263 | 77,937 | 71,811 | 107,505 | 167,563 |
Total Common Equity | 170,302 | 139,720 | 131,229 | 177,972 | 221,893 |
Minority Interest | -1,410 | -1,089 | -677.91 | 2,645 | - |
Shareholders' Equity | 170,207 | 139,800 | 130,551 | 180,617 | 221,893 |
Total Liabilities & Equity | 201,275 | 162,670 | 173,981 | 262,538 | 296,285 |
Total Debt | 6,611 | 6,734 | 13,086 | 38,260 | 16,843 |
Net Cash (Debt) | 6,843 | 227.6 | 861.52 | -3,461 | 4,793 |
Net Cash Growth | 2906.76% | -73.58% | - | - | - |
Net Cash Per Share | 96.19 | 3.28 | 13.98 | -65.39 | 102.30 |
Filing Date Shares Outstanding | 70.83 | 71.25 | 68.51 | 55.26 | 47.33 |
Total Common Shares Outstanding | 70.83 | 71.25 | 68.51 | 55.26 | 47.33 |
Working Capital | 14,130 | 1,004 | -9,698 | 711.79 | -1,238 |
Book Value Per Share | 2404.29 | 1961.02 | 1915.50 | 3220.48 | 4687.91 |
Tangible Book Value | 167,809 | 135,921 | 129,500 | 150,791 | 221,600 |
Tangible Book Value Per Share | 2369.09 | 1907.70 | 1890.26 | 2728.63 | 4681.73 |
Land | 261.48 | 261.48 | 261.48 | 261.48 | 261.48 |
Machinery | 2,675 | 2,673 | 2,545 | 1,905 | 1,650 |
Construction In Progress | - | - | - | 27 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.